X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Research And Views Archives | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Archives... Don't Miss Anything, Ever!

Here you will find all the research and views that we post on Equitymaster. Use the tools to customize the results to suit your preference!

















Authors
 

BASF

Jul 29, 2000

BASF India has reported a 26% growth in first quarter earnings on a 21% growth in the sales. One of the reasons for the improved performance is the higher sales of agrochemicals in the first quarter. This however is a seasonal business and sales drop by almost 20% in the second half. (The agrochemical business contributes around 32% to the company's annual turnover.)

Clariant makes a comeback

Jul 27, 2000

Clariant has reported a healthy growth in turnover of 15.4%. The growth is the upshot of its strategy of greater market penetration by focusing on new products in the specialty segment.

Clariant's perfomance stagnates

Jul 8, 2000

Clariant's top line recorded a growth of 7.5% to Rs 2,528 m. The growth has primarily come from greater market penetration by focusing on new products and developments in the specialty segment.

Creditable results from BASF

Jun 20, 2000

Despite a tough year BASF India, the 51% subsidiary of BASF AG, has declared good results. While the turnover has increased by 11%, it is the pre–tax profit, which has shown a sizeable improvement from 6.34% in FY99 to 8.79% in FY2000.

VRS provision hits Bayer's bottomline.

Mar 25, 2000

The near 50% decline in profitability is due to the write off on account of the Voluntary Retirement Scheme and a provision for gratuity.

Core competence back in vogue at AHP

Mar 22, 2000

American Home Products (AHP) has announced the sale of its agro–chemical business to BASF AG. Thus AHP would now become a pure health–care company. AHP is represented in India by Wyeth Lederle (healthcare unit) and Cyanamid India (agro–chemicals).

Decent results from Philips Carbon

Feb 5, 2000

Philips Carbon Black has reported decent results for the quarter. While the sales have grown by 18.2%, the net profit has increased 14.8%. The operating margins have also grown by 2.8% in the latest quarter as compared to the same quarter last year.

DCW posts 29% rise in net

Feb 2, 2000

DCW has posted a 29% rise in net profits during the quarter ended 31st December 1999. The company has benefited from a sharp rise in other income and a decline in interest expenditure.

Higher tax payout, depreciation lower net profit growth at Duphar Interfran

Feb 1, 2000

Duphar Interfran has demerged its pharmaceutical company from its chemical business. Thus this quarter's results include the results of the pharma business and this could not be proper indicator of the future.

Shasun Chemicals & Drugs Ltd has reported a big jump of 234% in net.

Feb 1, 2000

Shasun Chemicals has reported a net profit of Rs 63.8 m for the 3QFY2000. The main drivers to net are 17% growth in sales, 81% jump in other income and lower interest costs.

India Gelatine posts 9% decline in net

Feb 1, 2000

India Gelatine and Chemicals Limited has posted a 9% decline in net during the quarter ended 31st December 1999. The company has suffered an erosion in operating margins. However the rise in other income and the decline in interest expenditure have limited the downward pressure on the bottomline

Avon Orgaincs posts 118% jump in net

Jan 31, 2000

Avon Orgaincs has posted a 118% growth in net profits during the quarter ended 31st December 1999. The company has benefited from a sharp rise in net sales and a decline in interest expenditure.

Operating margins under pressure at Orchid Pharma

Jan 29, 2000

Orchid is a bulk drug manufacturer. The company's primary products are oral and sterile cephalosporins -cephalexin, cefradine and cefradroxyl. For the quarter ended December 1999 Orchid has reported a 38.7% jump in the topline. The operating margins excluding other income are under pressure. This has led to only a 19.3% jump in the bottomline. The company made placement of 10.7 million shares at Rs.175/ per share to Schroder Capital during the year.

Other income props Excel Industries bottomline

Jan 29, 2000

Excel Industries is a technical pesticide manufacturer. It's reported 4.1% jump in the topline with a 5.2% jump in the bottomline. The main contribution is howeever from other income which infact exceeded the pre-tax profit.

17% growth in topline for Centak Chemicals

Jan 29, 2000

Centak Chemicals has reported a decent performance for the quarter. Though margins are under pressure, the company has managed a 17% jump in the topline in a tough scenario for its pigments.

Daurala Organics Ltd reports a decline in net

Jan 28, 2000

Daurala Organics has reported a net of Rs 4.7 m for the 3QFY2000. It net sales went up by 19.6% to Rs 128 m however expenditure went up by 28.5% to Rs 104 m. As a result its net margins have fallen.

Savita Chemicals: Better than expected results

Jan 28, 2000

The company imports base oil the price of which have gone up by almost 70% in the last six months. Despite this the company has reported a 32% jump in turnover and a 78% jump in the bottomline. The operating margins have also gone up substantially. It is quite possible that the company would have booked its base oil imports earlier during the year. In that case the next quarter's profits could show a dip.

Punjab Chemicals net slumps 32%

Jan 27, 2000

Punjab Chemicals has witnessed 17.0% fall in sales to Rs 205.5 m. Net profit has declined 32.4% to Rs 19.2 m.

Fixed costs take a toll on Kerala Chemicals bottomline

Jan 27, 2000

While both sales have grown and operating margins have improved, Kerala Chemicals has still suffred a loss due to the high interest and depreciation expenses. The company had projected a profit of Rs.47.3 million for the full year but for the first nine months has run up a loss of Rs.56 million

Decent results from Clariant

Jan 25, 2000

Clariant has recorded a 13% growth in the topline with slightly improved operating margin. A reduction in the interest costs has propelled the bottomline by 19%


Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

MARKET STATS